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Introduction {#sec1}
============

Neuronal stress resistance is a critical component of health and activity. For many animals, neurons produced during development cannot be replaced and must last for the lifetime of the organism ([@bib4]). These neurons withstand a plethora of cellular stressors to maintain viability in the face of disease ([@bib63]), environmental afflictions ([@bib40], [@bib43], [@bib75]), and aging ([@bib12], [@bib14], [@bib45]). Understanding how neurons combat stress has wide-ranging implications for organismal health and quality of life.

Nicotinamide mononucleotide adenylyltransferase (NMNAT) is a housekeeping enzyme responsible for the synthesis of nicotinamide adenine dinucleotide (NAD^+^) in all living organisms ([@bib88]). In addition, NMNAT proteins are essential for neuronal maintenance and protection ([@bib2], [@bib8], [@bib24], [@bib47], [@bib64], [@bib70], [@bib73], [@bib74], [@bib81], [@bib84], [@bib86], [@bib87]). NMNAT has been shown to confer robust resistance against various stressors across many species, including hypoxia ([@bib1], [@bib82]), heat ([@bib1]), oxidative stress ([@bib17], [@bib20]), disease states ([@bib2], [@bib70], [@bib71], [@bib87]), and aging ([@bib50]).

Humans have three nonredundant *Nmnat* genes, whereas *Drosophila melanogaster* has a single *Nmnat* gene ([@bib3]) that is alternatively spliced into two distinct mRNA variants, RA and RB, giving rise to protein isoforms PC and PD, respectively ([@bib71]). Isoforms PC and PD share similar biochemical properties but have distinct subcellular localizations and divergent neuroprotective functions; isoform PD is cytosolic and a better neuroprotector than the RA-translated nuclear PC isoform ([@bib71]). A heat shock response element has been identified in the promoter of *Drosophila Nmnat*, allowing transcriptional upregulation of NMNAT pre-mRNA during stress conditions by stress transcription factor Heat Shock Factor (HSF) ([@bib1]). Although NMNAT pre-mRNA is slightly preferentially spliced to RA during basal conditions, it has been shown that the splicing of NMNAT pre-mRNA is shifted to RB in response to stress. Even though NMNAT pre-mRNA transcription is upregulated, only NMNAT splice variant RB is increased in stress conditions. Thus, a post-transcriptional "switch" is activated to promote the splicing of NMNAT pre-mRNA to RB and to serve as an effective homeostasis strategy to increase the production of the more protective protein PD isoform under stress ([@bib71]). However, the identity of the "switch" and the mechanism of regulating NMNAT pre-mRNA alternative splicing under stress remain unknown.

MicroRNAs are short (∼22 nt) noncoding RNAs involved in mRNA regulation ([@bib10], [@bib15]). MicroRNAs typically bind complementary nucleotide sequences in the 3′ UTR of target mRNAs through the RNA-induced silencing complex (RISC) ([@bib58]), which results in the degradation or translational repression of their targets ([@bib29]). *Drosophila* Argonaute 1, the homolog of mammalian Argonaute 2, is the major RISC component onto which microRNAs are loaded ([@bib85]). Although the vast majority of microRNA-target interactions result in decreased translation of the target, there are some reports of microRNAs upregulating translation of their target mRNAs ([@bib21], [@bib30], [@bib39], [@bib52], [@bib56], [@bib62], [@bib79], [@bib80]), often through binding the 5′UTR ([@bib39], [@bib62], [@bib79]). In addition, microRNAs have been implicated in stress response ([@bib22], [@bib53], [@bib57], [@bib83]) and homeostasis ([@bib7], [@bib19]). For example, miR-221 can protect human neurons from toxicity-induced stress ([@bib60]), several microRNAs have been implicated in fine-tuning the redox stress response ([@bib16]), and miR-393a enhances stress tolerance ([@bib90]). We hypothesize that microRNAs mediate NMNAT splice variant expression under stress, owing to their ability to directly influence mRNA levels post-transcriptionally. We thus seek to identify potential microRNAs that are involved in the regulation of NMNAT-mediated stress resistance.

In this study, we identified *dme-miR-1002*, a microRNA with the ability to regulate alternative splicing by binding to NMNAT pre-mRNA and upregulating NMNAT mRNA variant RB. Furthermore, we found that *miR-1002* is critical to *Drosophil*a thermotolerance and the stress response of NMNAT RB. Our findings suggest a previously unknown mode of gene expression regulation by non-coding RNAs and further reveal a new mechanism of maintaining homeostasis through stress resilience.

Results {#sec2}
=======

*miR-1002* Knockout Flies Have Decreased NMNAT RB and PD Expression {#sec2.1}
-------------------------------------------------------------------

*Drosophila melanogaster* has a single *Nmnat* gene producing two mRNA splice variants, RA and RB, which encode protein variants PC and PD, respectively. The pre-mRNA contains seven exons, with exons 1--4 commonly spliced and exons 5--7 alternatively spliced ([Figure 1](#fig1){ref-type="fig"}A). Since the enzymatic function required for NAD^+^ synthesis is encoded in exons 1--4, both protein isoforms PC and PD have enzymatic activity ([@bib71]). Exon 7 encodes a nuclear localization motif; therefore, isoform PC including exons 6 and 7 is nuclear localized, whereas isoform PD including exon 5 is localized in the cytoplasm and confers robust neuroprotective function ([@bib71]).Figure 1*miR-1002* Knockout Flies Have Decreased NMNAT RB and PD Expression(A) Diagram showing *Drosophila* NMNAT pre-mRNA, mRNA splice variants, and protein isoforms. dme-miR-1002 binding sequence on *DmNmnat* depicted at top, with box around Box 2 sequences.(B) NMNAT RNA levels in heads of control wild-type (*yw*), *miR-1002* homozygous knockout (*ΔmiR-1002*), and rescue flies (*ΔmiR-1002; UAS-miR-1002/elav-Geneswitch)*. Geneswitch flies were collected at 2DAE and fed RU486 for 5 days. RP49 used as reference gene. Normalized to control NMNAT RA. Bars indicate mean ± S.E.M. N = 4, One-Way ANOVA, Tukey\'s *post hoc*. \*p \< 0.05, \*\*p \< 0.01, \*\*\*p \< 0.001.(C) Western blot of control, *ΔmiR-1002,* and rescue fly heads. NMNAT PC and PD bands indicated at top. Actin loading control blot at bottom.(D) Quantification of (C). Band intensities were normalized to actin, then control NMNAT levels set to 1. Bars indicate mean ± S.E.M. N = 4, ns, not significant; \*p \< 0.05, One-Way ANOVA, Tukey\'s *post hoc*.(E) S2 cell dual luciferase activity assay. S2 cells were transfected with constructs expressing firefly luciferase linked to control wt NMNAT RB 3′UTR (RB 3′UTR control), firefly luciferase linked to NMNAT RB 3′UTR with the miR-1002 binding sequence mutated (RB 3′UTR seed mutant), or firefly luciferase only. In addition, miR-1002 or a scrambled miR-1002 control plasmid was transfected along with a Renilla luciferase plasmid. Firefly luciferase activity was normalized to Renilla luciferase activity levels, then standardized to the firefly luciferase only condition. Control + wt NMNAT RB 3′UTR was set to 1. Bars indicate mean ± S.E.M. N = 4, One-way ANOVA, Tukey\'s *post hoc*. ns, not significant.(F) Actinomycin D chase assay. S2 cells were transfected with plasmids expressing miR-1002 or a scrambled miR-1002 control. RNA was collected at indicated time points after actinomycin D treatment, then NMNAT RB levels quantified by qPCR. Nonlinear regression was performed for NMNAT RB remaining (normalized to RP49) from initial amount at each time point. Points represent mean ± S.E.M. of N = 3 per condition per time point.See also [Figure S1](#mmc1){ref-type="supplementary-material"}.

To identify potential regulators of *Drosophila Nmnat* expression, we performed a putative microRNA seed sequence scan on NMNAT RB 3′UTR via [microRNA.org](http://microRNA.org){#intref0010} ([@bib23], [@bib38]) and identified *dme-miR-1002* among the highest scoring microRNAs ([Figure 1](#fig1){ref-type="fig"}A), with a miRSVR score of −0.5339, where miRSVR scores below −0.1 indicate high sensitivity and specificity ([@bib6]).

To test if miR-1002 can modulate NMNAT RB levels, we obtained *miR-1002* homozygous knockout flies (*ΔmiR-1002*) and determined mRNA levels of variant RA and RB in heads by quantitative real-time PCR ([Figure 1](#fig1){ref-type="fig"}B). We observed significantly reduced levels of NMNAT RB, and increased RA, when compared with wild-type control (*yw*) flies. Furthermore, we found decreased NMNAT PD protein ([Figures 1](#fig1){ref-type="fig"}C and 1D) in the knockout flies. When we rescued these flies by conditional overexpression of miR-1002 in the knockout background (*ΔmiR-1002; elav-Geneswitch/UAS-miR-1002*), we observed a significant increase in NMNAT RB and a decrease in RA compared with knockout ([Figure 1](#fig1){ref-type="fig"}B). The rescue flies also had a significant increase in NMNAT PD ([Figures 1](#fig1){ref-type="fig"}C and 1D). This suggests that miR-1002 is important in regulating the expression of NMNAT RB mRNA and PD protein levels *in vivo*.

miR-1002 Shows No Effect in Altering the Stability of NMNAT RB {#sec2.2}
--------------------------------------------------------------

Reduced variant RB expression in *ΔmiR-1002* suggests that miR-1002 functions to increase the expression of its target mRNA, contrary to conventional 3′UTR-mediated mRNA degradation. To elucidate the molecular mechanisms of transcriptional regulation, we first tested the role of miR-1002 in 3′UTR-mediated mRNA stability using a dual luciferase activity assay ([Figure 1](#fig1){ref-type="fig"}E). Either the wild-type NMNAT RB 3′UTR sequence (RB 3′UTR control) or NMNAT RB 3′UTR with the miR-1002 seed sequence mutated (RB 3′UTR seed mutant) was inserted downstream of firefly luciferase in an expression vector. This plasmid was co-transfected into *Drosophila* S2 cells along with two additional plasmids: a Renilla luciferase expression plasmid (for transfection efficiency control) and either a plasmid overexpressing miR-1002 (miR-1002) or a control plasmid expressing a scrambled miR-1002 sequence (control). Forty-eight hours after transfection, we measured firefly and Renilla luciferase activity to test if miR-1002 can downregulate expression of firefly luciferase through NMNAT RB 3′UTR and if its binding sequence must be left intact for this to occur. In this reporter assay, we did not observe a significant difference in luciferase activity in cells co-transfected with the miR-1002 plasmid compared with the control plasmid. The same result was observed with both the wild-type and mutant NMNAT 3′UTR luciferase plasmids. This suggests that miR-1002 does not promote 3′UTR-mediated mRNA degradation.

However, it remains possible that miR-1002 can affect the stability of NMNAT RB indirectly through other regulatory pathways. To examine this possibility, we performed an actinomycin D chase assay where miR-1002 or a control was overexpressed by plasmid transfection in S2 cells and the endogenous NMNAT RB degradation rate was monitored after transcription was inhibited with actinomycin D ([@bib67], [@bib78]). As shown in [Figure 1](#fig1){ref-type="fig"}F, no significant difference in mRNA half-life for NMNAT RB was observed between cells expressing miR-1002 and control. Collectively, these results suggest that miR-1002 does not affect the stability of NMNAT RB in a 3′UTR-dependent or an indirect manner.

*In Silico* Analysis Reveals the miR-1002-Mediated Disruption of the Box 1-Box 2 Stem-Loop and Differential Minimum Free Energy Values in a Sequence-Specific Manner {#sec2.3}
--------------------------------------------------------------------------------------------------------------------------------------------------------------------

To understand how *miR-1002* affects NMNAT expression, we examined its binding sequence relative to known regulatory elements. Two key elements in intron 4 and exon 5 have previously been found to be critical for alternative splicing ([@bib68]). As shown in [Figure 1](#fig1){ref-type="fig"}A, complementary sequences in intron 4 (Box 1) and exon 5 (Box 2) must bind to form a pre-mRNA stem-loop to facilitate the skipping of exon 5 and inclusion of exon 6, thus forming the RA mRNA variant. When the stem-loop is not formed, exon 5 is preferentially spliced in, producing the RB variant.

The predicted binding sequence of miR-1002 overlaps Box 2 ([Figure 1](#fig1){ref-type="fig"}A, boxed nucleotides on DmNMNAT); we therefore hypothesized that miR-1002 binding to NMNAT pre-mRNA may interfere with formation of the stem-loop and shift splicing of NMNAT pre-mRNA toward RB. Furthermore, miR-1002 and NMNAT Box 2 sequences are conserved across *Drosophilae* ([Figure S2](#mmc1){ref-type="supplementary-material"}). There is remarkable conservation of the Box 2 sequences on NMNAT which miR-1002 is predicted to bind ([Figure S2](#mmc1){ref-type="supplementary-material"}A, red asterisks), and the sequence on miR-1002 that is predicted to bind them ([Figure S2](#mmc1){ref-type="supplementary-material"}B, red asterisks). This highlights the evolutionary importance of these sequences in regulating NMNAT expression.

To test our hypothesis, we used an *in silico* approach to predict the RNA secondary structure of various NMNAT and miR-1002 duplexes. In particular, we determined the RNA secondary structure of wild-type exon 4 and intron 5 of NMNAT using RNAfold of the Vienna RNA package ([@bib51]), utilizing default parameter settings. To visualize the corresponding minimum free energy structures, we utilized the FORNA web server ([@bib42]). We used this platform to model the structural consequences of miR-1002 binding to NMNAT^4−7^, as well as the effects of various mutations on this interaction. As previously indicated ([@bib68]), wild-type NMNAT^4−7^ RNA sequence forms a stem-loop structure via complementary binding of Box 1 (cyan) and Box 2 (blue), a result that we corroborate with our folding of the secondary structure of wild-type NMNAT exon 4 and intron 5 ([Figure 2](#fig2){ref-type="fig"}A). Assuming that miR-1002 binds its predicted RNA sequence in Box 2, the ability of the corresponding nucleotides to bind other nucleotides in wild-type exon 4 and intron 5 of NMNAT is restricted. Simulating such an assumption, we constrained binding of the corresponding nucleotides using RNAfold, allowing us to observe a massive disruption of the stem-loop structure ([Figure 2](#fig2){ref-type="fig"}B). The NMNAT^4−7^ mutations modeled in [Figures 2](#fig2){ref-type="fig"}C--2E encompass mutations within the miR-1002 binding sequence on NMNAT, precluding miR-1002 binding. When miR-1002\'s seed sequence outside of the binding stem is mutated (gray, mutated nucleotides in red), miR-1002 can no longer bind, allowing the stem-loop structure to form ([Figure 2](#fig2){ref-type="fig"}C). When miR-1002\'s binding sequence within Box 2 is mutated instead, miR-1002 binding is again impeded ([Figure 2](#fig2){ref-type="fig"}D). However, the stem-loop is expected to no longer form as a consequence of the disruption of the complementary sequences between Box 1 and Box 2. Finally, when sequences in Box 1 are mutated to be complementary to the Box 2 mutations, the stem-loop forms again ([Figure 2](#fig2){ref-type="fig"}E). However, corresponding mutations in the box 2 sequence prevent miR-1002 from binding.Figure 2*In Silico* Analysis Reveals miR-1002-Mediated Disruption of Box 1-Box 2 Stem-Loop Secondary Structure and Differential MFE Values in a Sequence-Specific Manner(A) FORNA minimum free energy model of the secondary structure of wt exon 4 and intron 5 sequences of NMNAT confirms the emergence of a stem between Box 1 (cyan) and Box 2 (blue) subsequences.(B) miR-1002 (yellow) binds a putative seed sequence (gray) and sequences in Box 2, disrupting the stem.(C--E) FORNA minimum free energy models of NMNAT where red sequences indicated nucleotide scrambled mutations. (C) Scramble mutation to miR-1002 seed; (D) scramble mutation to Box 2; (E) Box 1/Box 2 scramble mutation.(F) Minimum free energy values (kcal/mole) for various combinations of binding partners for NMNAT Box 2, calculated through duplexfold function in RNAStructure ([@bib69]). Top row depicts the three NMNAT Box 2 variants used in this analysis-NMNAT^wt^, the wild-type sequence of NMNAT Box 2 region; NMNAT^1002Seed^, NMNAT Box 2 with 4 nucleotides in the miR-1002 seed sequence scrambled; NMNAT^Box2m^, 5 nucleotides in Box 2 were scrambled. The left column depicts the five binding partners used---NMNAT^wt^, the wild-type Box 1 region; NMNAT^Box1m^, 5 nucleotides in Box 1 mutated in a complementary manner to the NMNAT^Box2m^ mutations; miR-1002^wt^, the wild-type miR-1002-5p sequence; miR-1002^Seed^, the seed sequence of miR-1002 mutated in a complementary manner to the NMNAT^1002Seed^ mutations; miR-1002^Box2^, with the Box 2 sequences on miR-1002 mutated in a complementary manner to the NMNAT^Box2m^ mutations. Box to the right of each sequence depicts MFE of duplex binding based on color.See also [Figure S2](#mmc1){ref-type="supplementary-material"}.

We then probed the effects of various mutations to NMNAT and miR-1002 on the binding energy of the predicted duplex ([Figure 2](#fig2){ref-type="fig"}F). Using RNA Structure 6.1 ([@bib69]), we calculated the minimum free energy of binding for various combinations of binding partners for NMNAT Box 2. The top row depicts the NMNAT exon 5 sequence used in the modeling wild-type (NMNAT^wt^), seed scramble (NMNAT^1002Seed^, four nucleotides within miR-1002\'s seed sequence on NMNAT were scrambled to disrupt miR-1002 binding as in [Figure 2](#fig2){ref-type="fig"}C), and Box 2 scramble (NMNAT^Box2^, five nucleotides within Box 2 were scrambled to disrupt miR-1002 binding as in [Figure 2](#fig2){ref-type="fig"}D). The left column shows the binding partners for NMNAT Box 2 used in this model. The top 2 are NMNAT Box 1 wild-type and NMNAT Box 1 scramble (NMNAT^Box1m^, five nucleotides within Box 1 were scrambled in a complementary manner to the Box 2 scramble as in [Figure 2](#fig2){ref-type="fig"}E). The bottom three are wild-type miR-1002 (miR-1002^wt^), seed scramble (miR-1002^Seed^, four nucleotides within miR-1002\'s seed sequence scrambled in a complementary manner to NMNAT^1002seed^, so as to restore miR-1002 binding), and Box 2 scramble (miR-1002^Box2^, five nucleotides within miR-1002\'s Box 2 sequence scrambled in a complementary manner to NMNAT^Box2m^, so as to restore miR-1002 binding).

Indeed, when miR-1002\'s binding to NMNAT is disrupted through mutations to the binding nucleotides (NMNAT^wt^ + miR-1002^Seed^(10), NMNAT^wt^ + miR-1002^Box2^(13), NMNAT^1002Seed^ + miR-1002^wt^(8), NMNAT^1002Seed^ + miR-1002^Box2^(14), NMNAT^Box2m^ + miR-1002^wt^(9), NMNAT^Box2m^ + miR-1002^wt^(12)), there is a significant increase in minimum free energy (MFE), indicating a less stable structure. MFE decreases when miR-1002 is mutated in a complementary manner to restore binding to NMNAT (NMNAT^1002Seed^ + miR-1002^Seed^(11), NMNAT^Box2m^ + miR-1002^Box2^(15)), indicating a strong and stable structure. In addition, Box 2 forming the stem-loop structure with Box 1 had low MFE values when the appropriate nucleotides were complementary (NMNAT^wt^ + NMNAT^wt^(1), NMNAT^1002Seed^ + NMNAT^wt^(2), NMNAT^Box2m^ + NMNAT^Box1m^(6)). Together, this analysis demonstrates how alternations in nucleotides have significant effects on the RNA secondary structure and binding energy and that the binding between miR-1002/Box 1 and Box 2 is direct and sequence specific.

miR-1002 Interferes with the Stem-Loop Mediated Alternative Splicing of NMNAT Pre-mRNA in a Sequence-Specific Manner {#sec2.4}
--------------------------------------------------------------------------------------------------------------------

To experimentally verify our *in silico* modeling results, we developed a cellular reporter assay to test the functional consequences of various mutations on NMNAT splicing ([Figure 3](#fig3){ref-type="fig"}A). *Drosophila* S2 cells were transfected with a reporter plasmid containing firefly luciferase cDNA and NMNAT pre-mRNA exons 4--7 driven from a UAS promoter (pUAS-luc2-NMNAT^4−7^). We co-transfected these cells with a plasmid expressing GAL4 and a scrambled miR-1002 sequence (pAC-GAL4-miR-1002-NegativeScramble) or wild-type miR-1002 (pAC-GAL4-miR-1002). The GAL4/UAS design ensures the co-expression of the Luc-NMNAT^4−7^ reporter and miR-1002-GAL4. We then extracted RNA from these cells and determined NMNAT splice variant mRNA levels by qPCR. As shown in [Figure 3](#fig3){ref-type="fig"}B, overexpression of miR-1002 along with wild-type NMNAT reporter (NMNAT^wt^) resulted in a significant increase in RB and decrease in RA (second set of bars) when compared with control (first set of bars). This is consistent with our hypothesis that miR-1002 interferes with stem-loop formation and shifts the splicing of NMNAT pre-mRNA toward NMNAT RB and away from RA. The upregulation of NMNAT RB by wild-type miR-1002 was not the result of increased transcription, as the RB/RA ratio was significantly increased ([Figure S3](#mmc1){ref-type="supplementary-material"}A). When miR-1002 with its seed sequence mutated (third set of bars, corresponding to [Figure 2](#fig2){ref-type="fig"}F10) or its Box 2 sequence mutated (fourth set of bars, corresponding to [Figure 2](#fig2){ref-type="fig"}F13) was co-transfected along with the wild-type reporter, there was no effect on NMNAT splicing.Figure 3miR-1002 Interferes with the Stem-Loop Mediated Alternative Splicing of NMNAT Pre-mRNA in a Sequence-Specific Manner(A) Schematic representation of S2 cell splicing assay. miR-1002 (yellow) is expressed from a pAC-GAL4 vector. GAL4 protein from pAC-GAL4 activates UAS elements in a reporter construct (pUAS-Luc2-NMNAT^4−7^). Pre-mRNA from the reporter plasmid is then alternatively spliced into two variants. RNA is extracted from cells, then qPCR is performed for the mature NMNAT mRNA splice variants. This experiment was performed with combinations of the mutations introduced in [Figure 2](#fig2){ref-type="fig"}.(B--E) Quantification of splicing assay. (B) wt pUASLuc-NMNAT^4−7^ transfected with three different PAC-GAL4-miR-1002 variants (miR-1002^wt^, second set of bars; miR-1002^Seed^, third set of bars; miR-1002^Box2^, fourth set of bars) and a negative control miR-1002 scramble plasmid (first set of bars). (C) pUAS-Luc2-NMNAT^4−7^ Seed scramble (corresponding to NMNAT^1002Seed^ from [Figure 2](#fig2){ref-type="fig"}) transfected with two different PAC-GAL4-miR-1002 variants (miR-1002^wt^, second set of bars; miR-1002^seed^, third set of bars) and a negative control miR-1002 scramble plasmid (first set of bars). (D) pUAS-Luc2-NMNAT^4−7^ Box2 scramble (corresponding to NMNAT^Box2m^ in [Figure 2](#fig2){ref-type="fig"}) transfected with two different PAC-GAL4-miR-1002 variants (miR-1002^wt^, second set of bars; miR-1002^Box2^,third set of bars) and a negative control miR-1002 scramble plasmid (first set of bars). (E) pUAS-Luc2-NMNAT^4−7^ Box1Box2 scramble (corresponding to NMNAT^Box1Box2m^ in [Figure 2](#fig2){ref-type="fig"}) transfected with two different PAC-GAL4-miR-1002 variants (miR-1002^wt^, second set of bars; miR-1002^Box2^, third set of bars) and a negative control miR-1002 scramble plasmid (first set of bars). Bars represent mean ± S.D. transcript levels for each condition and splice variant. Data were normalized to RP49 and control RA set to 1. N \> 4, One-Way ANOVA, Tukey\'s *post hoc*, ns, not significant; \*p \< 0.05, \*\*\*p \< 0.001. \*\*\*\*p \< 0.0001.See also [Figure S3](#mmc1){ref-type="supplementary-material"}.

To determine the sequence specificity of miR-1002 in regulating NMNAT alternative splicing, we tested the mutations modeled in [Figure 2](#fig2){ref-type="fig"}. As shown in [Figure 3](#fig3){ref-type="fig"}C, when the miR-1002 seed sequence outside of NMNAT Box 2 was mutated such that wild-type miR-1002 could no longer bind as in [Figure 2](#fig2){ref-type="fig"}C (NMNAT^1002Seed^), miR-1002 overexpression had no effect on RB expression (second set of bars, corresponding to [Figure 2](#fig2){ref-type="fig"}F8). This suggests that miR-1002 binding to its seed sequence is required for its effect on splicing. When miR-1002 itself was mutated in a complementary manner to restore binding, we observed a restoration of the downregulation in RA and upregulation in RB (far right bars, corresponding to [Figure 2](#fig2){ref-type="fig"}F11). Seed-mutated miR-1002 also increased the RB/RA ratio significantly ([Figure S3](#mmc1){ref-type="supplementary-material"}B).

In contrast, when miR-1002\'s binding sequence within Box 2 was mutated to disrupt both stem-loop formation and miR-1002 binding as in [Figure 2](#fig2){ref-type="fig"}D (NMNAT^Box2m^), there was no change in NMNAT variant expression in response to miR-1002 overexpression ([Figure 3](#fig3){ref-type="fig"}D). This was true with both wild-type miR-1002 (second set of bars) and miR-1002 with complementary mutations to NMNAT\'s Box 2 mutations to restore binding (third set of bars, corresponding to [Figure 2](#fig2){ref-type="fig"}F15). Additionally, the RB levels and RB/RA ratio ([Figure S3](#mmc1){ref-type="supplementary-material"}C) for all conditions increased relative to the control wild-type Nmnat^4−7^ plasmid, as the disruption of stem-loop results in exon 5 inclusion to produce RB. This further confirms the validity of our reporter system in assessing stem-loop formation.

Finally, when sequences in Box 1 were mutated in a complementary manner to the Box 2 mutations as in [Figure 2](#fig2){ref-type="fig"}E (NMNAT^Box1Box2m^), RB levels decreased ([Figure 3](#fig3){ref-type="fig"}E) and the RB/RA ratio decreased ([Figure S3](#mmc1){ref-type="supplementary-material"}D). This was expected since the complementary sequences of Box 1 and Box 2 allow the formation of the stem-loop and the exclusion of exon 5 to form RA. Although wild-type miR-1002 could not significantly alter NMNAT alternative splicing compared with control owing to its inability to bind NMNAT (first and second set of bars, corresponding to [Figure 2](#fig2){ref-type="fig"}F9), miR-1002 with a complementary Box 2 mutation was able to upregulate RB and downregulate RA (third set of bars, corresponding to [Figure 2](#fig2){ref-type="fig"}F15). With miR-1002 able to bind to NMNAT again, it could compete with Box 1 for binding to Box 2 and increase the RB/RA splicing ratio ([Figure S3](#mmc1){ref-type="supplementary-material"}D). Collectively, these results show that miR-1002 binding is necessary and sufficient to interfere with the stem-loop formation and shifts the splicing of NMNAT pre-mRNA to NMNAT RB.

miR-1002 Promotes the Inclusion of the RB-Exclusive Fifth Exon in an *In Vivo* Neuronal NMNAT Alternative Splicing Reporter {#sec2.5}
---------------------------------------------------------------------------------------------------------------------------

To assess if miR-1002 regulates the splicing of NMNAT pre-mRNA *in vivo*, we utilized a previously described alternative splicing reporter ([@bib71]), where the expression of AcGFP and DsRed are used as proxies for NMNAT RA and RB, respectively ([Figure 4](#fig4){ref-type="fig"}A). This is due to an in-frame AcGFP in the sixth exon and DsRed in the fifth exon.Figure 4miR-1002 Promotes the Inclusion of the RB-exclusive Fifth Exon in an *In Vivo* Neuronal NMNAT Alternative Splicing Reporter Model(A) Schematic representation of NMNAT reporter (*UAS-NMNAT*^*4−7*^*AltReport*) ([@bib71]). Genomic *NMNAT* at top with miR-1002 binding sequence indicated with white triangle. *NMNAT alternative splicing reporter* in middle, includes dsRed (Red R) in the fifth exon and AcGFP (Green G) in the sixth exon. Mature mRNA at bottom indicates RA-like splice variant with AcGFP, and RB-like variant with dsRed.(B) Confocal images of fly brains expressing NMNAT reporter and miR-1002, control (Luciferase), or miR-9a. Scale bar, 50 μm.(C and D) Quantification of (B). Bars represent mean of three midbrain areas per genotype ±S.E.M, normalized to control. N = 3, One-way ANOVA, Tukey\'s *post hoc*, \*p \< 0.05, \*\*p \< 0.01.

Pan-neuronal overexpression of miR-1002 in the brain resulted in early lethality (data not shown). To overcome the lethality, we used an inducible Gene-switch (GS) driver (*elav-GS-GAL4*) to activate expression in adult flies. RU486 (Mifepristone) feeding for 5 days induced expression of the alternative splicing reporter (*UAS-NMNAT*^*4−7*^*AltReport*) along with either miR-1002 (*UAS-miR-1002*), a non-targeting control microRNA miR-9a (*UAS-miR-9a*), or negative control luciferase (*UAS-Luc*). AcGFP and DsRed fluorescence in the fly brain was imaged and quantitated. As shown in [Figure 4](#fig4){ref-type="fig"}B, we observed a significantly higher DsRed and lower AcGFP fluorescence in the fly brain overexpressing miR-1002 when compared with controls ([Figures 4](#fig4){ref-type="fig"}C and 4D), indicating that miR-1002 overexpression promoted the inclusion of the fifth exon of the *NMNAT*^*4−7*^*AltReport* splicing reporter construct. These results suggest that miR-1002 overexpression shifts the splicing of NMNAT pre-mRNA toward variant RB in neurons *in vivo*.

*miR-1002* Mediates NMNAT Upregulation under Stress {#sec2.6}
---------------------------------------------------

NMNAT has been shown to protect many species against a variety of stresses, including heat, hypoxic, oxidative, proteotoxic, and aging stresses ([@bib2], [@bib50], [@bib54], [@bib70], [@bib71], [@bib91]). Furthermore, it has previously been reported that *NMNAT* is a stress response gene regulated by the stress transcription factor HSF ([@bib1]). Neuronal NMNAT PD protein and NMNAT RB mRNA, but not NMNAT RA, are upregulated in response to heat stress ([@bib71]). This demonstrates a stress-induced splicing "switch" to RB to confer increased protection. However, the mechanism of the variant-specific stress response "switch" to RB is unknown. miR-1002 presents an excellent candidate for this "switch" since it can bind to NMNAT pre-mRNA to obstruct the stem-loop formation and shift the splicing of NMNAT pre-mRNA into NMNAT RB. In addition, it has been reported that miR-1002 is upregulated in response to heat shock ([@bib26]) and oxidative stress induced by the treatment of a carcinogenic chemical Cr(VI) ([@bib13]). We wanted to investigate if the exclusive upregulation of NMNAT RB in these stress conditions is a result of miR-1002 enhancing the splicing of NMNAT pre-mRNA into RB. We subjected wild-type control *yw* and *ΔmiR-1002* flies to heat shock at 37°C for 45 min, a stress paradigm that has been shown to induce the highest level of NMNAT RB upregulation ([@bib71]). As expected, wild-type flies exhibited a significant upregulation in NMNAT RB but no significant change to RA in response to heat shock, whereas *ΔmiR-1002* flies lacked the increase in NMNAT RB in response to heat shock ([Figure 5](#fig5){ref-type="fig"}A). Moreover, there was a significant upregulation in NMNAT RA in the heat-shocked *ΔmiR-1002* flies. This supports a model in which NMNAT pre-mRNA transcription is increased during heat stress by heat shock transcription factor HSF, and the pre-mRNA is spliced almost exclusively to NMNAT RB owing to increased miR-1002. In the absence of miR-1002, the pre-mRNA is preferentially spliced into RA because of the structurally stable (low MFE) stem-loop formation.Figure 5*miR-1002* Is Critical for Thermotolerance and the Upregulation of NMNAT RB under Heat Stress(A) NMNAT RA and RB levels in control wild-type *yw* and *ΔmiR-1002* flies before and after heat shock. After NMNAT variant expression levels were normalized to RP49, control RB was set to 1. Bars represent mean ±S.E.M. N = 7 for baseline, N = 4 for heat stress. One-way ANOVA, Tukey\'s *post hoc*, \*p \< 0.05, \*\*p \< 0.01, \*\*\*\*p \< 0.0001.(B) Thermotolerance assay of control and *ΔmiR-1002* flies. Flies were subjected to heat shock and time taken to paralysis was recorded. Data points represent mean percent active flies at that time point. N \> 200 flies, Log rank test. p = 0.0031.(C) miR-1002 levels in heat shock. Wild-type flies were subjected to heat shock, and miR-1002 levels in heads quantified via qPCR and normalized to RP49 levels. Bars represent mean ±S.E.M. N=4, One-way ANOVA, Tukey\'s *post hoc*, \*p \< 0.05.

To assess the functional effects of *miR-1002* in stress response, we performed a thermotolerance assay whereby flies are subjected to a heat preconditioning (35°C for 30 min) followed by an extreme heat shock at 39°C, and the time to paralysis is recorded. It has been shown that loss of NMNAT leads to reduced latency to paralysis and that NMNAT overexpression confers paralysis resistance ([@bib1]). As shown in [Figure 5](#fig5){ref-type="fig"}B, *ΔmiR-1002* flies had a reduced latency to paralysis compared with wild-type flies (p = 0.0031). The median survival time for control and *ΔmiR-1002* were 60 and 50 min, respectively. At 50 min, 54.086% of control flies remained active, compared with 41.154% of knockout flies. This suggests that miR-1002 is critical for thermotolerance and enhances stress resistance in part though upregulating NMNAT RB as one of the key targets in the stress response network.

To determine if miR-1002 is upregulated during heat stress, we extracted the small RNA pool from wild-type fly heads after 15 and 45 min of heat shock. We detected a significant increase in miR-1002 level at both time points ([Figure 5](#fig5){ref-type="fig"}C). This demonstrates that miR-1002 is a heat-responsive microRNA and its increased transcription correlates with increased NMNAT splicing to RB. Higher levels of miR-1002 binding to NMNAT pre-mRNA facilitated efficient splicing to RB under stress.

Argonaute 1 Plays a Significant Role in miR-1002 Regulation of NMNAT Splicing {#sec2.7}
-----------------------------------------------------------------------------

It has been well characterized that during RISC formation, mature *Drosophila* microRNAs are typically loaded onto Argonaute 1 before binding to target transcripts ([@bib25], [@bib65]). We sought to determine the role of Argonaute 1 in miR-1002-mediated regulation of NMNAT splicing. We obtained Argonaute 1 hemizygous (*AGO1*^*+/−*^) mutant flies, which had previously been shown to have significantly reduced Argonaute 1 levels ([@bib66]). Heat stress treatment of *AGO1*^*+/−*^ flies resulted in no significant changes to RA or RB levels ([Figure 6](#fig6){ref-type="fig"}A), suggesting that Argonaute 1 is crucial to NMNAT\'s stress response.Figure 6*Argonaute 1* Is Required for miR-1002-Mediated NMNAT Regulation(A) NMNAT splice variant expression in response to heat shock in AGO1 hemizygous mutant flies. Flies were subjected to 45 min of heat shock at 37°C before RNA was extracted for qPCR. NMNAT levels normalized to RP49. No HS RA was set to 1. Bars represent as mean ± S.E.M. N = 4. One-way ANOVA, Tukey\'s *post hoc*.(B) NMNAT splice variants in miR-1002 overexpression flies. Control flies expressing LacZ from an elav-geneswitch promoter, flies expressing miR-1002, and flies expressing miR-1002 in an AGO1 hemizygous mutant background were fed RU486 for 5 days, then RNA extracted from heads. NMNAT splice variant levels were normalized to RP49. Control RA was set to 1. Bars represent mean ±S.E.M. N=4, One-way ANOVA, Tukey\'s *post hoc*, ns, not significant; \*\*p \< 0.01, \*\*\*p \< 0.001.(C) Western blot of S2 cell fractions before and after heat shock. S2 cells were subjected to 1 h of heat shock at 37°C, then lysed to purify subcellular fractions. Total cell input, cytoplasm, and nuclei fractions were run together, then blotted for AGO1, Histone H1 (nuclear marker), Calreticulin (ER marker), and α-Tubulin (cytoplasmic marker).(D) Quantification of (C). Band intensities of AGO1 were normalized to Tubulin for the total cell and cytoplasmic fractions, and Histone for the nucleic fractions. Approximately 6 × 10^4^ cells loaded into each whole-cell lane, ∼1 × 10^5^ cells worth of cytoplasm in each cytoplasm lane, and ∼3 × 10^5^ nuclei loaded into the nuclei lanes. Each fraction was normalized to its no HS condition. Bars represent mean ±S.E.M. N = 4 One-way ANOVA, Tukey\'s *post hoc*, \*\*p \< 0.01.(E) S2 cells were subjected to 1 h of heat shock at 37°C, then stained for DAPI and AGO1. Confocal microscopy was used to image and measure AGO1 in nuclei.(F) Quantification of (E). 1--3 are 3 different experiments, with box plot for all experiments combined. Each dot represents a different cell. At least 140 cells were counted for each condition. Box represents upper quartile to lower quartile, with line to represent median. Whiskers represent 5 and 95 percentiles. Student\'s t test, \*\*\*\*p \< 0.0001.See also [Figure S4](#mmc1){ref-type="supplementary-material"}.

The upregulation of NMNAT RB upon stress can be recapitulated by miR-1002 overexpression. A conditional overexpression of miR-1002 in fly brains resulted in a significant increase in NMNAT RB when compared with control LacZ overexpression ([Figure 6](#fig6){ref-type="fig"}B). In contrast, when miR-1002 was overexpressed in the *AGO1*^*+/−*^ background, we observed an abrogation of the NMNAT RB upregulation. This substantiates the essential role of Argonaute 1 in miR-1002 regulation of splicing.

Since most splicing occurs co-transcriptionally in the nucleus ([@bib9]), it is likely that AGO1-mediated miR-1002 regulation of splicing occurs in the nucleus. To investigate this possibility, we performed subcellular fractionation of S2 cells before and after heat shock to probe the nuclear, cytoplasmic, and whole-cell fractions for Argonaute 1, α-Tubulin (cytoplasmic marker), Calreticulin (ER marker \[[@bib27]\]), and Histone H1 (nuclear marker) ([Figures 6](#fig6){ref-type="fig"}C and 6D). Argonaute 1 was present in the nuclear fraction ([Figure 6](#fig6){ref-type="fig"}C), and it was significantly increased in the nucleus after heat shock ([Figure 6](#fig6){ref-type="fig"}D). The lack of tubulin and calreticulin staining in the nuclear lanes indicates that there is no contamination from cytoplasmic or ER AGO1 in those fractions. To further validate this finding, we performed immunostaining on S2 cells before and after heat shock. As shown in [Figures 6](#fig6){ref-type="fig"}E and 6F, although the majority of Argonaute 1 protein was present in the cytoplasm under normal conditions, nuclear Argonaute 1 was significantly increased after heat shock. Additionally, we performed FISH for miR-1002 in S2 cells ([Figure S4](#mmc1){ref-type="supplementary-material"}). We observed specific signal from the miR-1002 anti-sense probe in the nucleus of S2 cells, which suggests that miR-1002 can localize to the nucleus ([Figure S4](#mmc1){ref-type="supplementary-material"}B). However, we did not observe significant change in miR-1002 FISH signals with heat shock. Thus, the stress-mediated localization of miR-1002 to the nucleus requires further analysis to confirm. Collectively, these results provide evidence for the potential role of Argonaute 1 in the stress-induced nuclear activity of miR-1002 and splicing of NMNAT.

Discussion {#sec3}
==========

In this study, we discovered a ground-breaking mechanism of a microRNA regulating gene expression under stress. Our results demonstrate that microRNA miR-1002 regulates NMNAT variant-specific expression by interfering with the fourth intron-fifth exon stem-loop formation required for pre-mRNA alternative splicing in a direct, sequence-specific manner, rather than by the canonical 3′UTR-mediated mRNA degradation. Additionally, we found that miR-1002 and RISC component Argonaute 1 are critical for NMNAT-mediated neuronal stress resistance.

A New Role for microRNAs in Transcriptional Regulation---MIMOSAS {#sec3.1}
----------------------------------------------------------------

This new mechanism of gene regulation, which we term MIMOSAS ([MI]{.ul}croRNA-[M]{.ul}ediated [O]{.ul}bstruction of [S]{.ul}tem-loop [A]{.ul}lternative [S]{.ul}plicing) ([Figure 7](#fig7){ref-type="fig"}), presents a potential new layer through which cells can specifically control the expression of transcript variants. Although microRNAs are mostly studied in the context of mature mRNA 3′UTR binding and target transcript downregulation, MIMOSAS predicts the binding of microRNAs to interior intronic or exonic regions in the pre-mRNA of targets to regulate mRNA splicing. The outcome of such microRNA-pre-mRNA duplex binding allows mRNA expression modulation in an efficient and splice variant-specific manner. Importantly, MIMOSAS not only extends the functional repertoire of microRNAs, but also adds an exciting, novel example of long-range splicing and RNA secondary structure regulation ([@bib32], [@bib68]).Figure 7MIMOSAS, a Model for miR-1002 Regulation of NMNAT SplicingUnder basal conditions (left), NMNAT is preferentially spliced into the RA mRNA variant through stem-loop formation. Under stress (right), HSF upregulates transcription of NMNAT pre-mRNA. miR-1002 is also upregulated under stress, and miR-1002 enhances the splicing of NMNAT into the RB variant by preventing formation of the stem-loop. This upregulation serves as a stress-induced "switch" to increase protection through NMNAT PD.

Previous studies have suggested that non-coding RNAs can affect splicing. Gonzalez, et al. showed that a long non-coding RNAs (lncRNA) can promote the retention of a particular exon in FGFR2 alternative splicing ([@bib31]). Double-stranded RNAs can affect the splicing of genes associated with muscular dystrophy ([@bib48]). A small nuclear RNA has been found to regulate the splicing of Serotonin Receptor IIC, which is associated with Prader-Willi Syndrome ([@bib46]).

miR-1002\'s ability to regulate splicing of a target transcript offers new insight to how microRNAs control gene expression. It remains to be seen how prevalent this mechanism is and whether it is conserved. It was previously reported that 42.6% of microRNA target sites in human T-REx 293 cells were found in mRNA CDS regions ([@bib33]). A study mapping Kaposi sarcoma-associated herpesvirus microRNA binding sites in B cell lymphoma-derived cells and epithelial cells found that a majority of microRNA target sites were found within the CDS of mRNAs, not the 3′UTR ([@bib28]). Given that approximately 95% of multi-exonic human genes are alternatively spliced ([@bib44]), microRNA target sites in the exonic and intronic regions present ample opportunities for microRNAs to target and influence pre-mRNA splicing.

Our findings suggest that MIMOSAS through miR-1002 is mediated by Argonaute 1. Since most splicing occurs co-transcriptionally ([@bib59]), the nucleus is the most likely location for such microRNA-mediated regulation. Supporting this hypothesis is the detection of microRNAs in the nucleus. RNALocate lists over 200 examples of experimentally determined nuclear non-coding RNAs in neuronal or neuron-like cells ([@bib89]). On the other hand, Argonautes have also been shown to be localized to the nucleus and bind chromatin ([@bib11], [@bib34], [@bib35], [@bib65], [@bib77]). For example, Argonaute has been found to be nuclear localized in many cell types, including T47D ([@bib18]), 10G, ER293 ([@bib61]), HEK293, HeLa, and RPE-1 cells ([@bib72]). Our study detected Argonaute1 in the nuclear fraction, further supporting the notion that microRNA regulation of splicing may occur in the nuclear compartment. Specifically, our observation of the dependence of miR-1002 on Argonaute 1 and the stress-induced nuclear enrichment of Argonaute 1 supports a model in which Argonaute 1-miR-1002 localization to the nucleus during stress conditions facilitates the splicing of NMNAT pre-mRNA into the RB variant under stress.

MicroRNA miR-1002 Is a Part of the Stress Response Network {#sec3.2}
----------------------------------------------------------

Our previous study has found that, under stress, the NMNAT RB variant is upregulated to produce the neuroprotective protein isoform (PD). Therefore, alternative splicing of NMNAT functions as a switch to enhance neuroprotection under stress ([@bib71]). Excitingly, we discovered microRNA miR-1002 as the main driver of the "switch," as the upregulation of NMNAT RB under stress is eliminated in *ΔmiR-1002* flies ([Figure 5](#fig5){ref-type="fig"}A). Specifically, the observation that the heat shock upregulation of NMNAT RA in *ΔmiR-1002* flies mirrored the NMNAT RB increase in wild-type flies suggests that miR-1002 efficiently disrupts stem-loop and pushes all newly transcribed pre-mRNA into RB under stress. Without miR-1002, the newly transcribed NMNAT pre-mRNA was almost exclusively spliced to RA.

Our model predicts a novel role for miR-1002\'s regulation of NMNAT ([Figure 7](#fig7){ref-type="fig"}). In basal conditions, NMNAT pre-mRNA is spliced to RA with a slight preference via stem-loop formation ([@bib71]). Under stress, miR-1002 is upregulated and switches the splicing of newly transcribed NMNAT pre-mRNA almost exclusively to RB. Given the robust neuroprotective function of NMNAT isoform PD, miR-1002-mediated switch of alternative splicing enhances neuronal resistance to stress and confers organismal resilience. This is supported by the reduced thermotolerance observed in *ΔmiR-1002* flies. The modest reduction in thermotolerance suggests that miR-1002 is just one of the key players in the complex stress response network. Many other genes and proteins, including heat shock proteins, have been found to contribute to stress resistance ([@bib5], [@bib37], [@bib41], [@bib55], [@bib76]). Importantly, our study found that overexpression of miR-1002 in neurons was sufficient to shift alternative splicing toward RB *in vivo*, further substantiating the role of miR-1002 in enhancing NMNAT-mediated neuroprotection.

Our discovery of a novel mechanism of a microRNA regulating gene expression under stress unveils regulation of gene expression by noncoding RNAs in a state-specific manner and underscores the importance in considering alternative splicing modulation as therapeutic means. As 60% of point mutations associated with diseases have been found to be related to splicing defects ([@bib36]), several methods have been developed to modify alternative splicing. For example, duplex RNAs have also been used to modify alternative splicing in mammalian cells ([@bib48]), and a method of using single-stranded siRNAs has been developed to modify the splicing of a Dystrophin RNA, which is associated with Duchenne muscular dystrophy ([@bib49]). The results of our work introduce the possibility of microRNAs as tools to modulating alternative splicing. Although more work is required to identify other microRNA and target mRNA pairs, our work shows a promising new direction for conferring neuroprotection and organismal resilience.

Limitations of the Study {#sec3.3}
------------------------

Although our data confirm the functional outcome, the mechanistic details of miR-1002 splicing regulation remain elusive. Furthermore, more work is needed to determine if this process is conserved in mammals and how prevalent the regulation of pre-mRNA splicing by microRNAs is.

Methods {#sec4}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.
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Document S1. Transparent Methods, Figures S1--S4, and Table S1
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